The lack of enrichment of the pro-cancer pathways (cell proliferation-related and metastasis-related gene sets) in the low score group with poor prognosis is in agreement with the notion that ER-positive breast cancer is dependent on estrogen response for its aggressiveness that translates into survival. Here, ESR1 is linked to breast cancer.